Abstract
During the past decade, the critical role of sleep in health and disease has been underscored by research that further defines the relationship between sleep and myriad physiologic and psychological functions as well as quality of life. For many years, there was little exploration of the significance of sleep and sleep disorders in cancer patients; however, the past decade has seen a steady growth of inquiry in this area. These investigations have demonstrated the high frequency and significance of sleep disturbance as a symptom in cancer patients. They have also explored the complex interaction between sleep and other common cancer symptoms, most notably fatigue, depression, and pain, and have identified risk factors associated with the development of sleep problems in this population. Although treatment studies lag behind, reports of effective psychological and behavioral interventions for insomnia in cancer patients are increasing. Several studies are addressing pharmacotherapeutic intervention for hot flashes as a potential source of sleep disturbance. Other sleep disorders, most notably obstructive sleep apnea, also occur with some regularity in cancer patients.
Similar content being viewed by others
References and Recommended Reading
American Academy of Sleep Medicine: International Classification of Sleep Disorders, Diagnostic and Coding Manual, edn 2. Westchester, IL: American Academy of Sleep Medicine; 2005.
Hoekstra J, Vernooij-Dassen MJ, de Vos R, Bindels PJ: The added value of assessing the “most troublesome” symptom among patients with cancer in the palliative phase. Patient Educ Couns 2007, 65:223–229.
Gooneratne NS, Dean GE, Rogers AE, et al.: Sleep and quality of life in long-term lung cancer survivors. Lung Cancer 2007, 58:403–410.
Lee KA, Ward TM: Critical components of a sleep assessment for clinical practice settings. Issues Ment Health Nurs 2005, 26:739–750.
Portenoy RK, Thaler HT, Kornblith AB, et al.: The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 1994, 30A:1326–1336.
Cleeland CS, Mendoza TR, Wang XS, et al.: Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer 2000, 89:1634–1646.
Bruera E, Kuehn N, Miller MJ, et al.: The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 1991, 7:6–9.
Buysse DJ, Reynolds CF III, Monk TH, et al.: The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989, 28:193–213.
Sela RA, Watanabe S, Nekolaichuk CL: Sleep disturbances in palliative cancer patients attending a pain and symptom control clinic. Palliat Support Care 2005, 3:23–31.
Savard J, Morin CM: Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol 2001, 19:895–908.
Mystakidou K, Parpa E, Tsilika E, et al.: The relationship of subjective sleep quality, pain, and quality of life in advanced cancer patients. Sleep 2007, 30:737–742.
Mystakidou K, Parpa E, Tsilika E, et al.: Sleep quality in advanced cancer patients. J Psychosom Res 2007, 62:527–533.
Lövgren M, Tishelman C, Sprangers M, et al.: Symptoms and problems with functioning among women and men with inoperable lung cancer: a longitudinal study. Lung Cancer 2008, 60:113–124.
Reyes-Gibby CC, Chan W, Abbruzzese JL, et al.: Patterns of self-reported symptoms in pancreatic cancer patients receiving chemoradiation. J Pain Symptom Manage 2007, 34:244–252.
Chou FY, Dodd M, Abrams D, Padilla G: Symptoms, self-care, and quality of life of Chinese American patients with cancer. Oncol Nurs Forum 2007, 34:1162–1167.
Harding G, Cella D, Robinson D Jr, et al.: Symptom burden among patients with renal cell carcinoma (RCC): content for a symptom index. Health Qual Life Outcomes 2007, 5:34.
Berger AM, Farr LA, Kuhn BR, et al.: Values of sleep/wake, activity/rest, circadian rhythms, and fatigue prior to adjuvant breast cancer chemotherapy. J Pain Symptom Manage 2007, 33:398–409.
Le Guen Y, Gagnadoux F, Hureaux J, et al.: Sleep disturbances and impaired daytime functioning in outpatients with newly diagnosed lung cancer. Lung Cancer 2007, 58:139–143.
Bardwell WA, Profant J, Casden DR, et al.: The relative importance of specific risk factors for insomnia in women treated for early-stage breast cancer. Psychooncology 2008, 17:9–18.
Akechi T, Okuyama T, Akizuki N, et al.: Associated and predictive factors of sleep disturbance in advanced cancer patients. Psychooncology 2007, 16:888–894.
Hinds PS, Hockenberry M, Rai SN, et al.: Nocturnal awakenings, sleep environment interruptions, and fatigue in hospitalized children with cancer. Oncol Nurs Forum 2007, 34:393–402.
Guo Y, Musselman DL, Manatunga AK, et al.: The diagnosis of major depression in patients with cancer: a comparative approach. Psychosomatics 2006, 47:376–384.
Donovan KA, Jacobsen PB: Fatigue, depression, and insomnia: evidence for a symptom cluster in cancer. Semin Oncol Nurs 2007, 23:127–135.
Mao JJ, Armstrong K, Bowman MA, et al.: Symptom burden among cancer survivors: impact of age and comorbidity. J Am Board Fam Med 2007, 20:434–443.
Palesh OG, Collie K, Batiuchok D, et al.: A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer. Biol Psychol 2007, 75:37–44.
Sateia M, Byock I: Sleep disorders in palliative care. In Oxford Textbook of Palliative Medicine. Edited by Doyle D, Cherney N, Calman K. New York and Oxford: Oxford University Press; 2008 (in press).
Jacob E, Hesselgrave J, Sambuco G, Hockenberry M: Variations in pain, sleep, and activity during hospitalization in children with cancer. J Pediatr Oncol Nurs 2007, 24:208–219.
Taylor DJ, Mallory LJ, Lichstein KL, et al.: Comorbidity of chronic insomnia with medical problems. Sleep 2007, 30:213–218.
Barsevick AM: The concept of symptom cluster. Semin Oncol Nurs 2007, 23:89–98.
Hoffman AJ, Given BA, von Eye A, et al.: Relationships among pain, fatigue, insomnia, and gender in persons with lung cancer. Oncol Nurs Forum 2007, 34:785–792.
Miaskowski C, Cooper BA, Paul SM, et al.: Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis. Oncol Nurs Forum 2006, 33:E79–E89.
Krystal AD, Walsh JK, Laska E, et al.: Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 2003, 26:793–799.
Krystal AD, Erman M, Zammit GK, et al.: Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep 2008, 31:79–90.
Greenblatt DJ, Harmatz JS, Karim A: Age and gender effects on the pharmacokinetics and pharmacodynamics of ramelteon, a hypnotic agent acting via melatonin receptors MT1 and MT2. J Clin Pharmacol 2007, 47:485–496.
Guo Y, Young BL, Hainley S, et al.: Evaluation and pharmacologic management of symptoms in cancer patients undergoing acute rehabilitation in a comprehensive cancer center. Arch Phys Med Rehabil 2007, 88:891–895.
Epstein DR, Dirksen SR: Randomized trial of a cognitive-behavioral intervention for insomnia in breast cancer survivors. Oncol Nurs Forum 2007, 34:E51–E59.
Jin Y, Desta Z, Stearns V, et al.: CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J Natl Cancer Inst 2005, 97:30–39.
Schober CE, Ansani NT: Venlafaxine hydrochloride for the treatment of hot flashes. Ann Pharmacother 2003, 37:1703–1707.
Barton D, La VB, Loprinzi C, et al.: Venlafaxine for the control of hot flashes: results of a longitudinal continuation study. Oncol Nurs Forum 2002, 29:33–40.
Carpenter JS, Storniolo AM, Johns S, et al.: Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer. Oncologist 2007, 12:124–135.
Biglia N, Kubatzki F, Sgandurra P, et al.: Mirtazapine for the treatment of hot flushes in breast cancer survivors: a prospective pilot trial. Breast J 2007, 13:490–495.
Carpenter JS, Neal JG, Payne J, et al.: Cognitive-behavioral intervention for hot flashes. Oncol Nurs Forum 2007, 34:37.
Payne RJ, Hier MP, Kost KM, et al.: High prevalence of obstructive sleep apnea among patients with head and neck cancer. J Otolaryngol 2005, 34:304–311.
Friedman M, Landsberg R, Pryor S, et al.: The occurrence of sleep-disordered breathing among patients with head and neck cancer. Laryngoscope 2001, 111(Pt 1):1917–1919.
Nesse W, Hoekema A, Stegenga B, et al.: Prevalence of obstructive sleep apnoea following head and neck cancer treatment: a cross-sectional study. Oral Oncol 2006, 42:108–114.
Ursavas A, Karadag M, Burgazlioglu B, et al.: Relief from sleep apnea after radiation and chemotherapy. Clin Lung Cancer 2007, 8:502–503.
Walker JM, Farney RJ, Rhondeau SM, et al.: Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. J Clin Sleep Med 2007, 3:455–461.
Wang D, Teichtahl H: Opioids, sleep architecture and sleep-disordered breathing. Sleep Med Rev 2007, 11:35–46.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sateia, M.J., Lang, B.J. Sleep and cancer: Recent developments. Curr Oncol Rep 10, 309–318 (2008). https://doi.org/10.1007/s11912-008-0049-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11912-008-0049-0